The PROPHECI trial: a phase II, double-blind, placebo-controlled, randomized clinical trial for the treatment of pseudoxanthoma elasticum with oral pyrophosphate

Abstract Background /aims. Pseudoxanthoma Elasticum (PXE, OMIM 264800) is an autosomal, recessive, metabolic disorder characterized by progressive ectopic calcification in the skin, the vasculature and Bruch’s membrane. Variants in the ABCC6 gene are associated with low plasma pyrophosphate (PPi) co...

Полное описание

Библиографические подробности

Главные авторы:	Laetitia Clotaire, Isabelle Rubera, Christophe Duranton, Jocelyn Gal, Emmanuel Chamorey, Hélène Humeau, Samir Yamani, Christine Chiaverini, Serge Willoteaux, Bernard Padovani, Laurie Mourozeau, Adam Mainguy, Stéphanie Baillif, Ludovic Martin, Georges Leftheriotis
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2025-01-01
Серии:	Trials
Предметы:	Double-blind randomized clinical trial Pyrophosphate supplementation Arterial calcification Pseudoxanthoma elasticum
Online-ссылка:	https://doi.org/10.1186/s13063-024-08666-w
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!